In developing our Casanovo de novo sequencing model, we identified several problems with the nine-species benchmark . These included the deamidation problem mentioned above, as well as some uncertainty regarding how the FDR was controlled. Perhaps most importantly, we recognized that a non-negligible proportion of peptides are shared among the different species, with the highest overlap between human and mouse.